Literature DB >> 21527082

Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Giancarlo Maria Liumbruno1, Francesco Bennardello, Angela Lattanzio, Pierluigi Piccoli, Gina Rossetti.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21527082      PMCID： PMC3096863          DOI： 10.2450/2011.0075-10

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  368 in total

1.  Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery.

Authors:  Laurent Höhn; Alexandre Schweizer; Marc Licker; Denis R Morel
Journal:  Anesthesiology       Date:  2002-02       Impact factor: 7.892

2.  Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder.

Authors:  O J Hart; I W Klimberg; Z Wajsman; J Baker
Journal:  Surg Gynecol Obstet       Date:  1989-04

Review 3.  Cell salvage for minimising perioperative allogeneic blood transfusion.

Authors:  P A Carless; D A Henry; A J Moxey; D L O'connell; T Brown; D A Fergusson
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss.

Authors:  C R Valeri; G Cassidy; L E Pivacek; G Ragno; W Lieberthal; J P Crowley; S F Khuri; J Loscalzo
Journal:  Transfusion       Date:  2001-08       Impact factor: 3.157

Review 5.  Evidence-based treatment recommendations for uremic bleeding.

Authors:  Stephanie J Hedges; Sarah B Dehoney; Justin S Hooper; Jamshid Amanzadeh; Anthony J Busti
Journal:  Nat Clin Pract Nephrol       Date:  2007-03

6.  Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use.

Authors:  Michael A Sobieski; Mark S Slaughter; David E Hart; Patroklos S Pappas; Antone J Tatooles
Journal:  Perfusion       Date:  2005-01       Impact factor: 1.972

7.  Intraoperative cell salvage versus allogeneic transfusion during abdominal aortic surgery: clinical and financial outcomes.

Authors:  Miroslav Marković; Lazar Davidović; Nebojsa Savić; Radomir Sindjelić; Tatjana Ille; Marko Dragas
Journal:  Vascular       Date:  2009 Mar-Apr       Impact factor: 1.285

Review 8.  Perioperative complications of hypothermia.

Authors:  Luke Reynolds; James Beckmann; Andrea Kurz
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-12

9.  Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients.

Authors:  G Benoni; H Fredin
Journal:  J Bone Joint Surg Br       Date:  1996-05

Review 10.  The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility.

Authors:  Miguel Lozano; Joan Cid
Journal:  Transfus Med Rev       Date:  2003-01
View more
  35 in total

1.  Intra-operative transfusion management: the usefulness of point-of-care coagulation monitoring.

Authors:  Paolo Feltracco; Eugenio Serra; Carlo Ori
Journal:  Blood Transfus       Date:  2012-01-24       Impact factor: 3.443

2.  Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.

Authors:  Rafik Karaman; Hiba Ghareeb; Khuloud Kamal Dajani; Laura Scrano; Hussein Hallak; Saleh Abu-Lafi; Gennaro Mecca; Sabino A Bufo
Journal:  J Comput Aided Mol Des       Date:  2013-07-24       Impact factor: 3.686

3.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

4.  Does the application of GaAlAs laser and platelet-rich plasma induce cell proliferation and increase alkaline phosphatase activity in human dental pulp stem cells?

Authors:  Maryam Bidar; Aminmohammad Bahlakeh; Mahmoud Mahmoudi; Farzaneh Ahrari; Reza Shahmohammadi; Hamid Jafarzadeh
Journal:  Lasers Med Sci       Date:  2021-01-18       Impact factor: 3.161

5.  Low vacuum re-infusion drains after total knee arthroplasty: is there a real benefit?

Authors:  Manuel Muñoz; Andrés Cobos; Arturo Campos
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

6.  Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study.

Authors:  Manuel Muñoz; Susana Gómez-Ramírez; Elisa Martín-Montañez; Enrique Naveira; Javier Seara; José Pavía
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

7.  Blood cell counting in neonates: a comparison between a low volume micromethod and the standard laboratory method.

Authors:  Fabrizio Papa; Mauro Rongioletti; Marco Della Ventura; Francesco Di Turi; Maurizio Cortesi; Patrizio Pasqualetti; Maria Bernardetta Majolini; Valeria Collegiani; Marika Cicchese; Maria Letizia Notarmuzi; Rocco Agostino; Giancarlo Maria Liumbruno
Journal:  Blood Transfus       Date:  2011-07-18       Impact factor: 3.443

8.  Fibrinogen concentrate as haemostatic therapy in acquired bleeding disorders: not only a question of dosing strategies and thresholds.

Authors:  Giancarlo M Liumbruno; Stefania Vaglio; Enrico Capuzzo; Massimo Franchini
Journal:  Blood Transfus       Date:  2014-10-23       Impact factor: 3.443

9.  Indications and organisational methods for autologous blood transfusion procedures in Italy: results of a national survey.

Authors:  Liviana Catalano; Alessandra Campolongo; Maurizio Caponera; Alessandra Berzuini; Andrea Bontadini; Giuseppe Furlò; Patrizio Pasqualetti; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

10.  The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro.

Authors:  Christoph Johannes Schlimp; Janne Cadamuro; Cristina Solomon; Heinz Redl; Herbert Schöchl
Journal:  Blood Transfus       Date:  2012-12-13       Impact factor: 3.443
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.